Europe — EMA
Paliperidon Ratiopharm (Paliperidone Palmitate)
Paliperidone palmitate, the active ingredient in Paliperidon Ratiopharm, is an atypical antipsychotic presented as a long‑acting injectable suspension for intramuscular use.
Request sourcing
What is Paliperidone Palmitate?
Paliperidone palmitate, the active ingredient in Paliperidon Ratiopharm, is an atypical antipsychotic presented as a long‑acting injectable suspension for intramuscular use. It is indicated for the treatment of schizophrenia in adult patients. GNH USA supplies Paliperidon Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Paliperidon Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Paliperidone Palmitate used for?
Paliperidon Ratiopharm is an atypical antipsychotic that acts on dopamine and serotonin pathways to manage psychotic disorders.
- Schizophrenia: reduces the frequency of psychotic relapses and helps maintain symptom control. - Schizoaffective disorder: stabilises mood and psychotic symptoms. - Bipolar I disorder (maintenance): provides long‑term mood stabilization when used as an adjunct to other therapies.
What are the side effects of Paliperidone Palmitate?
Paliperidon Ratiopharm may cause a range of adverse reactions, most of which are dose‑dependent and reversible upon discontinuation.
Common Side Effects: - Injection site pain - Headache - Weight gain - Akathisia (restlessness - Drowsiness - Nasal congestion
Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Tardive dyskinesia - Severe orthostatic hypotension - Hyperglycaemia - Seizures - Elevated un …
What precautions apply to Paliperidone Palmitate?
The following … … … … … … …
